Phil Wolfson, MD, and Julane Andries, MFT MDMA-Assisted Psychotherapy for Anxiety in Life-Threatening Illness
28:25 min
CLEAR ALL
Psychedelics have an ancient and more recent history of medicinal-use. Administered in a supportive environment, with preparatory and integrative psychological care, psychedelic medicines are now being used to facilitate emotional breakthrough and renewed perspective.
1
MDMA, better known as ecstasy, molly, or one of a number of other street names, is a stimulant drug with unique prosocial effects. In this video, I discuss the current understanding of how MDMA acts on the brain to produce its effects.
Paul Stamets has been studying psilocybin mushrooms since the mid 1970's. Having written 6 books, including two field guides to psilocybin mushrooms, Paul has named four new psilocybin-active mushroom species.
Athletes who have sustained concussions are at a heightened risk for new injuries, including new concussions, when they return to play. This increased risk of new injury is likely due to ineffective evaluation and treatment protocols.
Scientists have discovered that the brain structures of traumatised soldiers and children change in the same way. Subscribe to BBC News HERE http://bit.ly/1rbfUog Check out our website: http://www.bbc.com/news Facebook: http://www.facebook.com/bbcworldnews Twitter: http://www.twitter.
The Neurophenomenology of the DMT State, presented by Christopher Timmermann from Imperial College London, UK
In this talk, Dr. Maté shared his insights into how disease can be the body’s way of saying ‘no’ to that which the mind cannot or will not acknowledge.
Dr Robin Carhart-Harris talks about his scientific research into the effects and potential therapeutic uses of psychedelic drugs. Join him as he discusses brain imaging work involving psilocybin, the active ingredient of magic mushrooms, and explains how the drug works in the brain.
Abstract: Highlighting the results of two fMRI studies and one MEG study with psilocybin and an fMRI study with MDMA, Carhart-Harris will report the effects of both drugs on regional brain activity and brain network organization.
Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.